[HTML][HTML] Recent advances in the treatment of osteoarthritis

S Grässel, D Muschter - F1000Research, 2020 - ncbi.nlm.nih.gov
Osteoarthritis (OA) is one of the most debilitating diseases and is associated with a high
personal and socioeconomic burden. So far, there is no therapy available that effectively …

Glucosinolates from cruciferous vegetables and their potential role in chronic disease: Investigating the preclinical and clinical evidence

EL Connolly, M Sim, N Travica, W Marx… - Frontiers in …, 2021 - frontiersin.org
An increasing body of evidence highlights the strong potential for a diet rich in fruit and
vegetables to delay, and often prevent, the onset of chronic diseases, including …

The metabolism of glucosinolates by gut microbiota

K Sikorska-Zimny, L Beneduce - Nutrients, 2021 - mdpi.com
Glucosinolates (GLS) and their derivatives are secondary plant metabolites abundant in
Brassicaceae. Due to the enzymatic reaction between GLS and myrosinase enzyme …

[HTML][HTML] Progerin accumulation in nucleus pulposus cells impairs mitochondrial function and induces intervertebral disc degeneration and therapeutic effects of …

X Xu, D Wang, C Zheng, B Gao, J Fan, P Cheng… - Theranostics, 2019 - ncbi.nlm.nih.gov
Progerin, a truncated unprocessed lamin A protein, causes tissue aging and degeneration.
In this study we explored the role of progerin in the pathogenesis of intervertebral disc …

Blueberries improve pain, gait performance, and inflammation in individuals with symptomatic knee osteoarthritis

C Du, A Smith, M Avalos, S South, K Crabtree, W Wang… - Nutrients, 2019 - mdpi.com
Osteoarthritis (OA) is the most common joint disorder in the world and is the most frequent
cause of walking related disability among older adults in the US, which brings a significant …

Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome

B Patel, GE Mann, SJ Chapple - Free Radical Biology and Medicine, 2018 - Elsevier
Diabetes and cardiometabolic disorders such as hypertension and obesity are major risk
factors for the development of cardiovascular disease, with a wealth of evidence suggesting …

Experimental therapeutics for the treatment of osteoarthritis

G Schulze-Tanzil - Journal of experimental pharmacology, 2021 - Taylor & Francis
Osteoarthritis (OA) therapy remains a large challenge since no causative treatment options
are so far available. Despite some main pathways contributing to OA are identified its …

Stable Sulforaphane Targets the Early Stages of Osteoclast Formation to Engender a Lasting Functional Blockade of Osteoclastogenesis

P Louka, IR Orriss, AA Pitsillides - Cells, 2024 - mdpi.com
Sulforaphane, the native but unstable form of SFX-01, is an antioxidant that activates the
NRF2 and inhibits the NF-KB pathways to achieve its actions. Resolving the mechanism (s) …

The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines

SJ Moon, J Jhun, J Ryu, JY Kwon, SY Kim, KA Jung… - PLoS …, 2021 - journals.plos.org
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is an important transcription factor that plays
a pivotal role in cellular defense against oxidative injury. Nrf2 signaling is involved in …

Sulforaphane inhibits osteoclastogenesis via suppression of the autophagic pathway

T Luo, X Fu, Y Liu, Y Ji, Z Shang - Molecules, 2021 - mdpi.com
Previous studies have demonstrated that sulforaphane (SFN) is a promising agent against
osteoclastic bone destruction. However, the mechanism underlying its anti-osteoclastogenic …